that blocks a protein called Trk, which is involved in cell
signaling and growth. Trk may be found in a mutated
(changed) form or at high levels in some types of cancer
cells. Blocking this protein may help keep cancer cells
from growing and may kill them.
LOXO-101 is being studied in
the treatment of some types of cancer. It is a type of
tyrosine kinase inhibitor and a type of targeted
therapy. Also called Trk inhibitor LOXO-101.